YMRC
NPSP

Yorktown Management & Research Company’s NPS PHARMACEUTICALS INC NPSP Stock Holding History

Yorktown Management & Research Company’s Portfolio NPSP Stock Details NPSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-8,300
Closed -$248K – 530
2014
Q1 		$248K Hold
8,300
– – 0.05% 316
2013
Q4 		$252K Buy
+8,300
New +$229K 0.05% 295

Other funds holding NPSP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Yorktown Management & Research Company's NPSP Position: Q2 2014 in Review

Yorktown Management & Research Company sold out of NPS PHARMACEUTICALS INC (NPSP) in Q2 2014, closing a stake of 8,300 shares — an estimated $248K sold.

Yorktown Management & Research Company first reported a position in NPSP in Q4 2013 and held it in 2 quarters. The position peaked at $252K in Q4 2013. 215 funds tracked by Wall St. Rank hold NPSP as of Q2 2014.

  • Yorktown Management & Research Company reported no remaining NPS PHARMACEUTICALS INC position as of Q2 2014 after selling out during the quarter.
  • Yorktown Management & Research Company sold 8,300 NPS PHARMACEUTICALS INC shares in Q2 2014, an estimated $248K.
  • Yorktown Management & Research Company first reported a position in NPS PHARMACEUTICALS INC in Q4 2013 and held it in 2 quarters.
  • Yorktown Management & Research Company's NPS PHARMACEUTICALS INC position peaked at $252K in Q4 2013.
  • 215 funds tracked by Wall St. Rank held NPS PHARMACEUTICALS INC as of Q2 2014.

Based on Yorktown Management & Research Company's 13F filing for Q2 2014, filed 23 Jul 2014.